Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORLATINIB vs LOVENOX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORLATINIB vs LOVENOX: Safety Overview

Metric LORLATINIB LOVENOX
Total FAERS Reports 5,508 488
Deaths Reported 1,542 61
Death Rate 28.0% 12.5%
Hospitalizations 1,232 163
Average Patient Age 56.5 yrs 63.2 yrs
% Female Patients 54.0% N/A
FDA Approval Date Nov 2, 2018 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A